Autism Susceptibility Candidate 2 (AUTS2) (N-Term) Peptide
Quick Overview for Autism Susceptibility Candidate 2 (AUTS2) (N-Term) Peptide (ABIN8095308)
Target
Origin
Source
Application
-
-
Protein Region
- N-Term
-
Purpose
- AUTS2 Peptide - N-terminal region
-
Sequence
- PQERVEKRQT PLTKKKREAL TNGLSFHSKK SRLSHPHHYS SDRENDRNLC
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- AUTS2 (Autism Susceptibility Candidate 2 (AUTS2))
-
Background
-
Background Information: This gene has been implicated in neurodevelopment and as a candidate gene for numerous neurological disorders, including autism spectrum disorders, intellectual disability, and developmental delay. Mutations in this gene have also been associated with non-neurological disorders, such as acute lymphoblastic leukemia, aging of the skin, early-onset androgenetic alopecia, and certain cancers. Alternative splicing results in multiple transcript variants encoding different isoforms.
Alternative Symbols: MRD26, FBRSL2
-
Molecular Weight
- 139 kDa
-
Gene ID
- 26053
-
NCBI Accession
- NP_001120703
-
UniProt
- Q8WXX7
Target
-